Work

PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors

Year: 2021

Type: article

Study design: Observational Study

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2020.12.008

Authors: Miriam Grazia Ferrara, Maurizio Martini, Ettore D’Argento, Chiara Forcella, Emanuele Vita, Vincenzo Di Noia, Isabella Sperduti, Mirna Bilotta, Marta Ribelli, Paola Damiano, Antonella Cannella, Alessio Stefani, Sara Pilotto, Carmine Carbone, Geny Piro, Michele Milella, Giampaolo Tortora, Emilio Bria

Institutions: Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Humanitas Gavazzeni, Instituto Nazionale Tumori Regina Elena, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, AstraZeneca, Novartis, Roche, Meso Scale Diagnostics, Associazione Italiana per la Ricerca sul Cancro, Università Cattolica del Sacro Cuore

Awards: G2372024546, G427962841, G4399338010, G934871739

OpenAlex ID: W3127056995

FWCI: 1.783

Cites: 62

Cited by: 16

Related to: 10